Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-08-19 00:00:00 ET · period of report 2022-08-18 · accession 0001209191-22-046929 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-19 | 2022-08-18 | FATE | Dulac Edward J III | CFO | S - Sale | $29.81 | -5,135 | 137.2K | -4% | -$153.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-18 | S | D | 432 | $30.41 | 136,801 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-18 | S | D | 4,703 | $29.75 | 137,233 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $29.29 to $30.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. |